Literatur – 4. Früher ist nicht zwangsläufig besser

1. Raffle A, Gray M. Screening: evidence and practice. Oxford: Oxford University Press, überarb. Nachdruck, 2009.

2. Sense About Science. Making sense of screening. London: Sense About Science, 2009. Zugänglich unter:

3. Goodman MT, Gurney JG, Smith MA, et al. Sympathetic nervous system tumors. In: Ries LAG, Smith MA, Gurney JG, et al (eds). Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. National Cancer Institute, SEER Program. NIH Pub. No.994649. Bethesda, MD, 1999. SEER Pediatric Monograph. Zugänglich unter

4. Mullassery D, Dominici C, Jesudason EC, et al. Neuroblastoma: contemporary management. Archives of Disease in Childhood – Education and Practice 2009; 94:177–185.

5. Morris JK. Screening for neuroblastoma in children. Journal of Medical Screening 2002; 9: 56.

6. Raffle A, Gray M. op. cit., S. 89–92.

7. Welch HG. Should I be tested for cancer? Maybe not and here’s why. Berkeley and Los Angeles: University of California Press, 2004, S. 77.

8. Cosford PA, Leng GC, Thomas J. Screening for abdominal aortic aneurysm. Cochrane Database of Systematic Reviews, 2007, Issue 2, Art. No.: CD002945.

9. Welch HG. Screening mammography – a long run for a short slide? New England Journal of Medicine 2010; 363: 1276–1278.

10. Heath I. It is not wrong to say no. Why are women told only the benefits of breast screening and none of the possible harms? BMJ 2009; 338: 1534.

11. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database of Systematic Reviews 2011, Issue 1. Art. No.: CD001877.

12. Kösters JP, Gøtzsche PC. Regular self-examination or clinical examination for early detection of breast cancer. Cochrane Database of Systematic Reviews 2003, Issue 2. Art. No.: CD003373. (keine Änderungen, Update, Issue 3, Juli 2008.)

13. McPherson K. Should we screen for breast cancer? BMJ 2010:340:c3106.

14. Cancer Research UK. Prostate cancer – UK incidence statistics. Aktualisiert am 23. Dezember 2010.

15. Chapman S, Barratt A, Stockler M. Let sleeping dogs lie? What men should know before getting tested for prostate cancer. Sydney: Sydney University Press, 2010. pdf zugänglich unter:

16. Holmström B, Johansson M, Bergh A, et al. Prostate specific antigen for early detection of prostate cancer: longitudinal study. BMJ 2009; 339: b3537.

17. Djulbegovic M, Beyth RJ, Neuberger MM, et al. Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. BMJ 2010; 341: c4543.

18. Stark JR, Mucci L, Rothman KJ, et al. Prostate cancer screening: the controversy continues. BMJ 2009; 339: b3601.

19. National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. New England Journal of Medicine 2011; 365: 395–409.

20. Moynihan R. Beware the fortune tellers peddling genetic tests. BMJ 2010; 341:c7233.

21. Thornton H. The screening debates: time for a broader approach? European Journal of Cancer 2003; 39: 1807–1809.

22. Adapted from Wilson JMG, Jungner G. Principles and practice of screening for disease. Public health paper no 34. Geneva: World Health Organization, 1968.

23. COMARE 12th Report: The impact of personally initiated X-ray computed tomography scanning for the health assessment of asymptomatic individuals. Pressemitteilung vom 19. Dezember 2007.

24. Department of Health. Better protection for patients having «MOT» scans:

25. Food and Drug Administration. Radiation-emitting products: Computed tomography and full-body CT scans – what you need to know: